Introduction {#Sec1}
============

Regular exercise has been identified along with diet and medication as one of the three components of good diabetes therapy \[[@CR1]\]. Structured exercise intervention programmes have been reported to be as effective as pharmaceutical strategies in improving glycaemic control \[[@CR2]--[@CR5]\] and/or cardiovascular risk profile \[[@CR6], [@CR7]\] in type 2 diabetes patients. Despite the growing body of scientific evidence on the health benefits of exercise intervention, most meta-analyses report a lack of studies that have tried to assess the long-term efficacy of exercise intervention in type 2 diabetes patients \[[@CR3]--[@CR5], [@CR7]--[@CR9]\]. In general, exercise intervention studies implement endurance and resistance type exercise, supervised by a physical therapist \[[@CR10]--[@CR17]\]. The long-term adherence to these (so-called) medical fitness programmes has been shown to range between 10 and 80% \[[@CR11], [@CR18]--[@CR20]\]. Financial costs per patient are considerable in such programmes. Brisk walking exercise has been proposed as a less expensive alternative, with a good clinical outcome when patients are frequently counselled by motivated, supportive physicians \[[@CR6], [@CR21], [@CR22]\]. However, brisk walking programmes mainly consist of endurance type exercise activities. As combined endurance and resistance type exercise training has been reported to be of greater clinical benefit \[[@CR3], [@CR23]\], it is conceivable that the long-term efficacy of a medical fitness programme is greater than that of a brisk walking programme.

In the present study, we compared the changes in glycaemic control and cardiovascular risk profile following the prescription of 12 months of either supervised group-based brisk-walking or of a more individualised medical fitness programme in a large population of type 2 diabetes patients (*n* = 92) in a primary healthcare setting. We report our results for changes in HbA~1c~ values as a primary outcome parameter, with blood pressure, plasma lipid levels, insulin sensitivity by homeostasis model assessment (HOMA), body composition, physical fitness, programme adherence and health-related quality of life as secondary outcome parameters. Given the greater improvements in glycaemic control following combined endurance and resistance type exercise training as opposed to each separately \[[@CR3], [@CR23]\], we hypothesised that a medical fitness programme would result in a significantly greater decline in HbA~1c~ than brisk walking.

Methods {#Sec2}
=======

Participants {#Sec3}
------------

From June till December 2005, 493 patients with type 2 diabetes were preselected from a population of 12,197 patients attending a primary healthcare centre that offers structured and guideline-based \[[@CR24]\] diabetes care programmes. After 5 months of active recruitment by two nurse practitioners and four general practitioners, a total of 76 (=15.4%) patients were willing to participate in supervised exercise sessions three times a week for a period of at least 1 year. The type 2 diabetes patients selected had been diagnosed more than 3 months prior to screening according to the WHO criteria \[[@CR25]\]. Exclusion criteria were: presence of (silent) cardiac or peripheral vascular disease, orthopaedic limitations and/or diabetic foot ulceration. To increase sample size, the exercise intervention programme was subsequently advertised in local newspapers, which yielded another 26 potential study candidates. In total, 99 type 2 diabetes patients agreed to participate in either brisk walking or medical fitness programmes. Potential study candidates performed a graded exercise test on a cycle ergometer (Medifit; Medifit Systems, Maarn, the Netherlands) using a ramp protocol \[[@CR26]\]. Cardiac function was monitored using a 12-lead electrocardiogram and blood pressure was measured to detect malignant hypertension. Of the 99 selected patients, three did not show up and four were excluded because of an abnormal stress-ECG. The remaining 92 volunteers were randomly allocated to either brisk walking (*n* = 49) or medical fitness (*n* = 43) programmes, by subsequently drawing a sequentially numbered opaque, sealed envelope (Fig. [1](#Fig1){ref-type="fig"}). Laboratory personnel and the physician in charge of the graded exercise tests and randomisation procedure were blinded to the selection outcome of each participant. Drug prescriptions of each patient were recorded through an electronic database system operated through a network of local pharmacies. As part of the diabetes protocol in the healthcare centre, all type 2 diabetes patients consulted a dietitian and/or diabetes nurse educator annually for dietary guidance. Baseline participant characteristics are provided in Table [1](#Tab1){ref-type="table"}. The nature and the risks of the exercise intervention were explained to all participants before written informed consent was obtained. This study was approved by the local Medical Ethical Committee of the Máxima Medical Centre, Veldhoven, the Netherlands. Since the study protocol was planned before 2005, official pre-trial registration at international trial registers was not performed. Fig. 1Study flow diagramTable 1Participants' baseline characteristicsCharacteristicTotal (*n* = 92)Brisk walking (*n* = 49)Medical fitness (*n* = 43)Age (years)60 ± 961 ± 959 ± 9Men/women (*n*)47/4527/2220/23Duration of diabetes (years)5 ± 55 ± 45 ± 5BW (kg)94.3 ± 18.494.1 ± 18.194.5 ± 19.0BMI (kg/m^2^)32.3 ± 5.532.1 ± 5.232.5 ± 6.0*W*~max~ (W)156 ± 47155 ± 49157 ± 45Estimated $\documentclass[12pt]{minimal}
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Exercise intervention {#Sec4}
---------------------

**Overview** Two different exercise intervention programmes were implemented over a 12-month period, during which three brisk walking or medical fitness sessions were performed each week. The exercise load was progressive in nature and had components of resistance and endurance type exercise according to the American Diabetes Association/American College of Sports Medicine guidelines \[[@CR27]\].

**Brisk walking programme** The weekly volume of brisk walking consisted of three 60 min exercise sessions. During the first 3 months participants were supervised by certified exercise trainers and a physical therapist. Group size varied between 15 and 25 patients. After 3 months, certified trainers guided and supervised the training sessions, while the physical therapist was visited on a consultation basis. The endurance type exercise consisted of brisk walking (5--6 km/h), with a focus on interval type endurance exercise training. During the intervention period the intensity was gradually increased and averaged 75 ± 5% of maximum heart frequency, as determined during the maximal cycle ergometer test. The resistance type exercise training consisted of resistance and floor exercises using individual body weight and/or elastic bands (The Hygenic Corporation, Akron, OH, USA). Further details on the brisk walking programme are provided in Electronic supplementary material (ESM) Table [1](#MOESM1){ref-type=""}.

**Medical fitness programme** The medical fitness programme consisted of three exercise sessions per week. Endurance type exercise consisted of interval type exercise on a home trainer, elliptical trainer or rowing ergometer with an average intensity of 73 ± 2% of maximum heart frequency. All training sessions were tailored to individual performance capacity. Resistance type exercise consisted of a selection of eight different exercises targeting upper and lower body muscle groups. Over a period of 6 months the training volume of the medical fitness programme was progressively increased from three times 30 min per week (90 min/week) towards a total of 180 to 225 min per week. Further details on the medical fitness programme are provided in ESM Table [1](#MOESM1){ref-type=""}.

**Energy expenditure and monitoring blood glucose** Based on average heart rate and indirect calorimetry measurements performed during either brisk walking \[[@CR28]\] or circuit resistance training in elderly \[[@CR29]\] participants, energy expenditure in both exercise interventions was estimated to range between 0.23 and 0.33 kJ kg^−1^ min^−1^. Given the participants' bodyweights, the exercise interventions should be regarded as moderate intensity. Participants were provided with blood glucose monitor systems and test strips (A. Menarini Diagnostics, Valkenswaard, the Netherlands) and during the first month of brisk walking or medical fitness were advised to assess capillary blood glucose levels ∼30 min before and after exercise. Patients were instructed to report recurrent hypoglycaemic events to their diabetes nurse educator or general practitioner. For logistic reasons no systematic enquiries on mild hypoglycaemic events were performed.

**Financial cost of the intervention programmes** Direct yearly costs for the individualised medical fitness programme were Euro 853 per participant and consisted of an ECG-stress test, supervision and consultations by a physical therapist, and the use of fitness centre facilities. The direct costs of the group-based brisk walking programme averaged Euro 396 per participant. Costs consisted of an ECG-stress test, supervision and consultation by a physical therapist, and a brisk walking membership fee. Other healthcare-related costs were not assessed.

Outcome variables {#Sec5}
-----------------

**Resting heart rate and blood pressure** Resting heart rate and blood pressure were determined in a supine position before and at 6 and 12 months after initiating the exercise programme. Heart rate was stored and averaged through a heart rate monitoring system (CO2ntrol; Tildesign, Zeewolde, the Netherlands). Average systolic and diastolic blood pressure were determined (HEM-907; Omron Healthcare, Hoofddorp, the Netherlands) from five successive measurements.
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**Blood analyses** Two weeks before and at 3, 6, 9 and 12 months after initiating the exercise programme, fasting blood samples were collected. Blood samples collected before and after 3 and 9 months of intervention were analysed for HbA~1c~ and basal glucose concentration. On the evening prior to blood sampling, participants remained fasted from 00:00 hours onwards. They arrived at the laboratory at 08:00 hours, having travelled by car or public transport. After 5 to 10 min of rest, a venous blood sample was collected from an antecubital vein. Blood samples were collected in tubes containing a glycolytic inhibitor (sodium fluoride) and an anticoagulant (potassium oxalate), immediately centrifuged for 5 min at 1,000×*g* and 4°C, after which aliquots of plasma were immediately frozen in liquid nitrogen and stored at −80°C until analyses. Plasma glucose (dehydrogenase assay), triacylglycerol (lipase/peroxidase assay) concentrations, and total serum cholesterol (peroxidase/cholesterol-esterase assay), HDL-cholesterol (peroxidase esterase assay) and LDL-cholesterol (according to the Friedewald formula if triacylglycerol was \<4.5 mmol/l, otherwise through direct peroxidase esterase assay) were analysed (Synchron LX20; Beckman Coulter, Fullerton, CA, USA). Plasma insulin was determined in duplicate by electrochemiluminescence-immunoassay (Elecsys 2010; Roche, Mannheim, Germany). Because of cross-sensitivity in the latter assay, exogenous insulin users were excluded from this analysis. HOMA insulin resistance index \[[@CR32]\] was assessed to monitor changes in insulin sensitivity \[[@CR33]\]. To determine HbA~1c~, 3 ml blood samples were collected and analysed by high-performance liquid chromatography (HA8160 Menarini; A. Menarini Diagnostics, Florence, Italy).

Quality-of-life assessment {#Sec6}
--------------------------

Health-related quality-of-life was measured with the RAND 36-Item Health Survey 1.0 \[[@CR34], [@CR35]\] before and after 12 months of exercise intervention.

Statistical analyses {#Sec7}
--------------------

We calculated that 74 persons (37 per group) were needed to have 80% power to detect a moderate 0.65 SD difference in HbA~1c~ as primary endpoint parameter between brisk walking and medical fitness programme, with an *α* of 0.05. Sample size was exceeded to allow for an estimated withdrawal of ∼15%. Data were analysed according to the intention-to-treat (ITT) principle. To minimise type I errors and loss of power \[[@CR36]\], endpoint analyses according to the last observation carried forward principle were performed for missing values at 12 months follow-up. To assess whether physiological differences existed between the long-term application of brisk walking and medical fitness programme, post hoc analyses were performed for individuals actively participating for 10 months or more. Data are expressed as means ± SD. ANOVA repeated measures was used to determine differences between baseline and status after 12 months of exercise intervention. Unpaired Student's *t*, *χ*^2^ and Mann--Whitney *U* tests were used to test whether long-term changes observed in brisk walking differed from those seen in the medical fitness programme. Significance was set at the 0.05 level of confidence. Pearson's correlation calculation was used to test for linear relationships between long-term changes in dependent variables. All statistical calculations were performed using SPSS 10.1 (SPSS, Chicago, IL, USA).

Results {#Sec8}
=======

Characteristics of the study population {#Sec9}
---------------------------------------

Following randomisation there were no significant differences in baseline characteristics, sex and anthropometry between brisk walking and medical fitness programme groups (Table [1](#Tab1){ref-type="table"}).

Programme adherence, follow-up and adverse events {#Sec10}
-------------------------------------------------

After 6 months of intervention, 22 (45%) brisk walking participants and 13 (30%) medical fitness programme participants (*p* = 0.15) were no longer participating (ESM Table [2](#MOESM2){ref-type=""}). After 12 months, 18 (37%) brisk walking and 19 (44%) medical fitness participants respectively were still actively participating with mean adherence levels of 75 ± 16% and 68 ± 13% (*p* \> 0.05) for the 156 available exercise sessions (ESM Table [2](#MOESM2){ref-type=""}). Besides motivational reasons (25%), orthopaedic-related co-morbidities, such as overuse injuries and/or subclinical osteoarthritis of the lower extremities, formed the main reason for dropout in 48 and 50% of the brisk walking and medical fitness programme participants, respectively (Fig. [1](#Fig1){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}). The distribution of missing data points was similar and not statistically different between groups (*p* \> 0.05). Table 2Adverse medical eventsEventsBrisk walking (*n* = 49)Medical fitness (*n* = 43)Adverse events related to exercise intervention1512 Shoulder pain/chronic tendinopathy of rotator cuff01 (Aggravation of) low back pain22 Aggravation of pre-existing osteoarthritis in hip or knee joint64 Shin splints/lower leg pain10 Chronic tendinopathy of Achilles tendon/plantar fascia31 Other/generalised musculoskeletal discomfort33Adverse events not related to exercise intervention46 Medical event requiring hospitalisation^a^33 Other serious medical event^b^13Participants with adverse event resulting in withdrawal1917Data are number of participating diabetes patients that experienced an adverse event throughout the 12 months follow-up period^a^Hospitalisations were related to: arthroscopic knee surgery (brisk walking, *n* = 1), elective surgery for chronic abdominal aortic aneurysm (brisk walking, *n* = 1), elective cataract surgery (brisk walking, *n* = 1), elective knee joint replacement (medical fitness, *n* = 1), bacterial pneumonia (medical fitness, *n* = 1), elective varicose veins surgery (medical fitness, *n* = 1, did not result in withdrawal from study).^b^Other serious medical events requiring medical attention were: otitis externa (brisk walking) *n* = 1, atrial fibrillation (medical fitness) *n* = 1, newly diagnosed myocardial ischaemia (medical fitness) *n* = 1, and newly diagnosed carcinoma of the mammary gland (medical fitness) *n* = 1

Glycaemic control {#Sec11}
-----------------

According to ITT analyses, changes in HbA~1c~ values following the prescription of brisk walking or medical fitness intervention were identical (95% CI −0.42, 0.43; *p* = 0.99) (Table [3](#Tab3){ref-type="table"}). A total of 12 patients (brisk walking, *n* = 5; medical fitness, *n* = 7) had been prescribed higher doses of blood glucose-lowering medication throughout the follow-up period. When these participants were excluded from our ITT analysis, HbA~1c~ increased by 0.05% (95% CI −0.41, 0.51; *p* = 0.82) in brisk walking as compared with medical fitness programme. Post hoc analyses of long-term active participants (≥10 months with mean adherence level of 62 ± 17 and 70 ± 18% in brisk walking and medical fitness groups, respectively) showed that, independently of changes in prescribed blood glucose-lowering drugs, HbA~1c~ in the brisk walking group increased by 0.53% (95% CI 0.07, 1.00; *p* = 0.025) as compared with the medical fitness group (ESM Table [3](#MOESM3){ref-type=""}). Table 3Changes in diabetes outcome (ITT analysis)VariableChange from baseline to 12 monthsMean ± SD*n*Mean ± SD*n*Difference95% CI*p* ValueHbA~1c~ (%) Total7.13 ± 1.36926.99 ± 1.2671   Brisk walking group7.18 ± 1.42497.08 ± 1.3738    Medical fitness group7.08 ± 1.29436.89 ± 1.1333    Intragroup comparisons         Intragroup comparison total    −0.14−0.39, 0.030.153  Intragroup comparison brisk walking    −0.11−0.51, 0.150.464  Intragroup comparison medical fitness    −0.18−0.45, 0.090.176 Brisk walking vs medical fitness    0.00−0.42, 0.430.985BMI (kg/m^2^) Total32.3 ± 5.59231.8 ± 5.489    Brisk walking group32.1 ± 5.24931.9 ± 5.048    Medical fitness group32.5 ± 6.04331.7 ± 5.941    Intragroup comparisons         Intragroup comparison total    −0.5−1.1, 0.10.108  Intragroup comparison brisk walking    −0.2−0.6, 0.30.471  Intragroup comparison medical fitness    −0.8−2.0, 0.30.152 Brisk walking vs medical fitness    0.7−0.5, 1.90.237Fasting plasma glucose (mmol/l) Total8.44 ± 2.81928.21 ± 2.3771    Brisk walking group8.64 ± 2.83498.33 ± 2.6438    Medical fitness group8.21 ± 2.80438.06 ± 2.0533    Intragroup comparisons         Intragroup comparison total    −0.23−0.72, 0.250.345  Intragroup comparison brisk walking    −0.31−0.96, 0.340.344  Intragroup comparison medical fitness    −0.15−0.91, 0.610.699 Brisk walking vs. medical fitness    −0.16−1.14, 0.820.744HOMA^a^ Total5.55 ± 3.68685.60 ± 3.3854    Brisk walking group5.86 ± 3.56375.75 ± 3.2030    Medical fitness group5.19 ± 3.58315.43 ± 3.6424    Intragroup comparisons         Intragroup comparison total    0.05−0.50, 0.620.833  Intragroup comparison brisk walking    −0.12−1.11, 0.850.794  Intragroup comparison medical fitness    0.24−0.19, 0.740.241 Brisk walking vs medical fitness    −0.40−1.52, 0.720.479Resting heart rate (bpm) Total73.4 ± 11.89169.6 ± 13.977    Brisk walking group72.6 ± 11.84868.3 ± 15.041    Medical fitness group74.4 ± 11.84371.0 ± 12.436    Intragroup comparisons         Intragroup comparison total    −3.9−5.9, −1.80.000  Intragroup comparison brisk walking    −4.3−7.4, −1.10.009  Intragroup comparison medical fitness    −3.4−5.9, −0.90.010 Brisk walking vs medical fitness    −0.9−4.9, 3.20.678Systolic blood pressure (mmHg) Total148.5 ± 18.191137.5 ± 15.577    Brisk walking group150.3 ± 18.948138.9 ± 16.341    Medical fitness group146.3 ± 17.143135.9 ± 14.636    Intragroup comparisons         Intragroup comparison total    −10.9−14.0, −7.80.000  Intragroup comparison brisk walking    −11.4−15.9, −6.80.000  Intragroup comparison medical fitness    −10.4−14.7, 6.20.000 Brisk walking vs medical fitness    −0.9−7.1, 5.3)0.768Diastolic blood pressure (mmHg) Total81.9 ± 10.69176.6 ± 8.377    Brisk walking group81.3 ± 10.84875.9 ± 8.841    Medical fitness group82.6 ± 10.44377.4 ± 7.736    Intragroup comparisons         Intragroup comparison total    −5.3−7.1, −3.60.000  Intragroup comparison brisk walking    −5.4−7.8, 2.90.000  Intragroup comparison medical fitness    −5.2−7.8, −2.70.000 Brisk walking vs medical fitness    −0.1−3.6, 3.40.949Total cholesterol level (mmol/l) Total4.70 ± 0.86884.53 ± 0.9465    Brisk walking group4.83 ± 0.89474.61 ± 0.9235    Medical fitness group4.54 ± 0.12414.44 ± 0.9630    Intragroup comparisons         Intragroup comparison total    −0.16−0.32, −0.010.035  Intragroup comparison brisk walking    −0.22−0.45, 0.010.064  Intragroup comparison medical fitness    −0.10−0.30, 0.100.307 Brisk walking vs medical fitness    −0.12−0.42, 0.190.453LDL-cholesterol level (mmol/l) Total2.83 ± 0.76882.70 ± 0.7964    Brisk walking group2.90 ± 0.82472.72 ± 0.8535    Medical fitness group2.74 ± 0.69412.68 ± 0.7229    Intragroup comparisons         Intragroup comparison total    −0.12−0.26, 0.010.070  Intragroup comparison brisk walking    −0.18−0.38, 0.020.080  Intragroup comparison medical fitness    −0.06--0.25, 0.120.493 Brisk walking vs medical fitness    −0.11−0.38, 0.160.401HDL-cholesterol level (mmol/l) Total1.09 ± 0.28881.10 ± 0.2965    Brisk walking group1.10 ± 0.23471.09 ± 0.2635    Medical fitness group1.07 ± 0.33411.11 ± 0.3230    Intragroup comparisons         Intragroup comparison total    −0.01--0.02, 0.040.570  Intragroup comparison brisk walking    −0.01−0.06, 0.040.629  Intragroup comparison medical fitness    0.03−0.01, 0.080.129 Brisk walking vs medical fitness    −0.05−0.12, 0.020.172Triacylglycerol level (mmol/l) Total1.88 ± 0.99881.79 ± 0.9164    Brisk walking group2.00 ± 1.08471.94 ± 0.9835    Medical fitness group1.74 ± 0.88411.61 ± 0.7929    Intragroup comparisons         Intragroup comparison total    −0.09−0.25, 0.060.239  Intragroup comparison brisk walking    −0.06−0.33, 0.170.646  Intragroup comparison medical fitness    −0.13−0.27, 0.060.120 Brisk walking vs medical fitness    −0.02−0.29, 0.330.892RAND-36 (score 0--100 scale) Total71 ± 158970 ± 1558    Brisk walking group69 ± 154668 ± 1531    Medical fitness group73 ± 154371 ± 1427    Intragroup comparisons         Intragroup comparison total    −0.6−2.4, 1.20.503  Intragroup comparison brisk walking    0.1--2.7, 2.80.969  Intragroup comparison medical fitness    −1.4−3.8, 1.10.261 Brisk walking vs medical fitness    1.4−2.2, 5.00.438Data are means ± SD. *n*=number of valid measurements. ^a^For HOMA calculations exogenous insulin users (*n* = 13) were excluded

Resting heart rate and blood pressure {#Sec12}
-------------------------------------

Following the 12 month exercise intervention, resting heart rate in the brisk walking group was reduced by 0.9 beats per min (bpm) (CI −7.1, 5.3; *p* = 0.68) as compared with medical fitness group. No significant differences in blood pressure response were observed between the two interventions (Table [3](#Tab3){ref-type="table"}). After excluding participants who were prescribed higher doses of antihypertensive drugs (brisk walking, *n* = 5; medical fitness, *n* = 7), mean arterial blood pressure decreased by 0.9 mmHg (95% CI −5.6, 3.9; *p* = 0.94) in the brisk walking as compared with medical fitness group. A post hoc analysis of 46 long-term active participants showed a non-significant difference in mean arterial blood pressure of −3.5 mmHg (95% CI −9.2, 2.2; *p* = 0.22) in the brisk walking compared with the medical fitness programme (ESM Table [3](#MOESM3){ref-type=""}).

Blood lipid profile {#Sec13}
-------------------

After 12 months, the overall fasting lipid profile did not differ between the two groups (Table [3](#Tab3){ref-type="table"}). When participants (brisk walking, *n* = 9, medical fitness, *n* = 7) who were prescribed more blood lipid-lowering agents were excluded, HDL-cholesterol had changed by −0.05 mmol/l (95% CI −0.12, 0.02; *p* = 0.17) in the medical fitness compared with the brisk walking group.

Body composition and workload capacity {#Sec14}
--------------------------------------

Body composition (BMI) did not change (Table [3](#Tab3){ref-type="table"}). Workload capacity as measured during cycle ergometry averaged 155 ± 49 and 157 ± 45 W in the brisk walking and medical fitness programme groups, respectively, changing by −4.3 W (95% CI −9.1, 0.5; *p* = 0.078) in the former and by −2.5 W (95% CI −10, 5.6; *p* = 0.53) in the latter, with a non-significant difference of −1.8 W (95% CI −10.5, 6.9; *p* = 0.68) in brisk walking compared with medical fitness programme participants. Maximum heart rates recorded during ergometry averaged 146 ± 22 and 152 ± 19 bpm at baseline, and 152 ± 21 and 149 ± 22 bpm following 12 months of exercise intervention in the brisk walking and medical fitness groups, respectively (*p* \> 0.05). In our long-term active brisk walking participants, *W*~max~ changed by −6.3 W (95% CI −16.5, 3.9; *p* = 0.22) as compared with their medical fitness programme counterparts. No significant correlations were found between changes in HbA~1c~ values and changes in workload capacity (Δ*W*~max~, Pearson's *R* = 0.02, *p* = 0.93, *n* = 38) or body weight (Pearson's *R* = 0.18, *p* = 0.225, *n* = 45).

Quality of life assessment {#Sec15}
--------------------------

A total of 89 and 58 participants completed the RAND-36 questionnaire at baseline and after 12 months of intervention, respectively. Reliability and internal consistency was excellent with Cronbach's alpha of 0.93 and 0.91 respectively. No significant difference in changes of total RAND-36 scores were observed between the two intervention groups (*p* \> 0.05; Table [3](#Tab3){ref-type="table"}).

Discussion {#Sec16}
==========

It has been firmly established that physical activity counselling \[[@CR37]\] and participation in structured exercise intervention programmes \[[@CR15], [@CR19]\] improves glycaemic control. However, long-term intervention studies on the clinical benefits of different types of exercise intervention programmes in type 2 diabetes patients are lacking. In the present study, we compared the clinical benefits of 12 months of a group-based brisk walking programme versus a more individualised medical fitness programme. ITT analysis showed that the prescription of a group-based, brisk walking programme is not necessarily inferior to a more individualised medical fitness programme with regard to glycaemic control and markers for cardiovascular risk profile (Table [3](#Tab3){ref-type="table"}). Our data therefore imply that most patients with type 2 diabetes will achieve more or less equal long-term therapeutic benefits from a low-impact brisk walking programme as opposed to a more individualised medical fitness programme. Nevertheless, long-term programme adherence and the possibility of dropout should be taken into consideration when prescribing either type of exercise intervention for a patient with type 2 diabetes. Independently of the provided level of guidance and infrastructure, 60% of the patients dropped out of the exercise programme during the 12 month intervention period, with no differences in adherence and dropout patterns between brisk walking and medical fitness programme. Although motivational factors explained 25% of the dropout in both exercise programmes, almost 50% of the dropout was attributed to orthopaedic-related co-morbidities and overuse injuries of the lower extremities. The latter was not anticipated, since clinically relevant orthopaedic limitations, such as a history of osteoarthritis of the hip or knee joint, were defined as exclusion criteria for participation in either exercise intervention programme. Apparently, subclinical joint disease and/or degeneration of myotendineous structures become apparent when physical activity levels are increased. Stiffening of connective tissue due to non-enzymatic advanced glycation end-product formation \[[@CR38]\], as well as decreased collagen turnover due to ageing and chronic disuse \[[@CR39]\], could be responsible for the impaired response to increased musculoskeletal loading in these patients. Although more fundamental clinical research is warranted, the high incidence of overuse injuries in the present study adds to the results described in another study \[[@CR23]\], suggesting that in unselected, non-study populations dropout will be even greater. Therefore, it might be advisable to implement a more gradual and less intense exercise regimen to allow myotendineous structures to adapt to increased loading. Moreover, before prescribing therapeutic exercise, diabetes healthcare workers should carefully consider obesity- and diabetes-related musculoskeletal deconditioning \[[@CR40]--[@CR42]\]. Such programmes should probably focus even more on resistance type exercise activities \[[@CR43], [@CR44]\] to bring patients to a level at which they are able to participate and adhere to more generic diabetes intervention programmes. It has also been suggested that psychological strategies such as motivational interviewing \[[@CR45]\] or booster sessions \[[@CR21], [@CR46]\] might help to further improve programme adherence. Nevertheless, more long-term, tailored exercise intervention studies are warranted to further define the most effective and feasible exercise interventional strategy.

The absence of a significant decline in blood HbA~1c~ levels in brisk walking participants does not imply that the prescription of low-impact, endurance type exercise has no therapeutic value \[[@CR3], [@CR7], [@CR27], [@CR47]--[@CR49]\]. In fact, we observed significant improvements in blood pressure control following either type of exercise intervention (Table [3](#Tab3){ref-type="table"}). Although reliable assessment of actual drug use was not possible in the present study, the improvements in blood pressure occurred independently of changes in the prescription of antihypertensive medication. However, the lack of a non-exercise control group in the present study makes it impossible to speculate on cause and effect, since changes in blood pressure from baseline might also, or at least partly, be explained by the Hawthorne effect, for example, or by familiarisation with blood pressure measurement protocols. Nevertheless, our data suggest that the structured application of group-based brisk walking and supervised medical fitness programmes tends to have a similar impact on cardiovascular risk profile.

In conclusion, the prescription of group-based brisk walking represents an equally effective interventional strategy to modulate glycaemic control and cardiovascular risk profile in type 2 diabetes patients compared with a more individualised medical fitness programme. General deconditioning, musculoskeletal overuse injuries and lack of motivation limit the benefits of long-term exercise intervention as an add-on to a comprehensive diabetes care programme. Future diabetes exercise intervention programmes in primary healthcare settings should consider diabetes-related co-morbidities and patient motivation as important factors, which determine both long-term programme adherence and the associated clinical benefits.
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